Top Gainers and Losers from the Prism Market View Index

SOLO was the biggest winner of the entire group and OPRX was the largest detractor.

Share this article:

About the Author:

Lipocine Wins Health Canada Approval for Oral Testosterone Therapy TLANDO

Editor Prism MarketView

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup